The PDX 49 represents a unique case of myeloid sarcoma within this cohort, and retained STR, morphology and fusions (CBL – USP2, SMG5–CTSS, and KPNA1–CBFA2T2) identical to those of the original tumor. This evidence concerns the gene SMG5 and neoplasm.